Advertisement
EU Stocks

ALEUP.PA stock plunges 20% in after-hours trading on May 11

May 11, 2026
5 min read

Key Points

ALEUP.PA stock plunged 20% in after-hours trading at €0.0056.

Europlasma faces severe financial distress with negative earnings and cash flow.

Trading volume surged to 31.2 million shares amid liquidation pressure.

Company's market cap of €16,596 reflects complete investor loss of confidence.

Be the first to rate this article

ALEUP.PA stock collapsed 20% in after-hours trading on May 11, 2026, closing at just €0.0056 on EURONEXT. Europlasma S.A., the French waste management and plasma technology company, saw massive trading volume of 31.2 million shares, significantly above its average of 29 million. The sharp decline reflects mounting investor concerns about the company’s financial health. With a market cap of just €16,596 and negative earnings per share of -88.61, ALEUP.PA remains one of the market’s most distressed industrial stocks. We examine what’s driving this severe selloff and what it means for shareholders.

Advertisement

Why ALEUP.PA Stock Crashed Today

ALEUP.PA stock’s 20% plunge reflects deeper structural problems at Europlasma S.A. The company trades at microscopic valuations with a price-to-sales ratio of just 0.00028, indicating severe market skepticism. Revenue per share stands at €215.38, yet the company burns cash with negative free cash flow of -€95.63 per share.

Meyka AI rates ALEUP.PA with a grade of B, suggesting a HOLD recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. However, the company’s fundamentals tell a different story. Operating margins are deeply negative at -47.2%, and the company posted a net loss margin of -74.4%. These metrics explain why institutional investors continue to exit positions.

Market Sentiment and Trading Activity

Trading Activity

Volume surged to 31.2 million shares during after-hours trading, representing 91% of the stock’s average daily volume. This concentration suggests forced liquidations or panic selling rather than organic market activity. The day’s range was tight, trading between €0.0056 and €0.0064, indicating limited price discovery in thin markets.

Liquidation Pressure

Europlasma faces severe liquidity challenges. The current ratio of 0.80 means the company has only €0.80 in current assets for every €1 of current liabilities. Working capital stands at negative €13.5 million, creating urgent cash needs. Track ALEUP.PA on Meyka for real-time updates on liquidity developments and insider activity.

Financial Deterioration and Valuation Collapse

ALEUP.PA stock has experienced catastrophic value destruction. Over the past year, the stock fell 99.98%, and the five-year decline is a complete -100%. The year-to-date loss stands at -97.2%, with a six-month decline of -98.6%. These figures indicate the company has essentially been written off by the market.

The company’s debt-to-market-cap ratio of 1,039 reveals extreme financial distress. Europlasma carries €64.58 in interest-bearing debt per share while the stock trades at €0.0056. Earnings are deeply negative at -€88.61 per share, making traditional valuation metrics meaningless. The company’s tangible book value is negative at -€75.73 per share, suggesting shareholders have no equity cushion.

Sector Context and Competitive Position

Europlasma operates in the Industrials sector, specifically Waste Management, which trades at an average PE of 26.16 on EURONEXT. The sector includes major players like General Electric and Caterpillar, companies with strong profitability and positive cash flows. Europlasma’s performance stands in stark contrast to these industry peers.

The company’s business model focuses on plasma torch systems for hazardous waste treatment and renewable energy from biomass. However, negative operating cash flow of -€82.92 per share suggests the business cannot generate cash from operations. With 1,840 full-time employees and headquarters in Pessac, France, Europlasma faces mounting pressure to restructure or seek strategic alternatives. Recent analyst coverage highlights diversification challenges across waste management competitors, making Europlasma’s specialized focus increasingly risky.

Advertisement

Final Thoughts

ALEUP.PA stock’s 20% crash in after-hours trading reflects years of accumulated financial distress now reaching a critical point. Europlasma S.A. faces a perfect storm: negative profitability, severe cash burn, liquidity crisis, and a market cap that has essentially evaporated. The company’s debt burden is unsustainable relative to its market value, and working capital deficits signal immediate operational stress. With earnings per share at -€88.61 and free cash flow deeply negative, the company cannot fund operations or service debt from business performance. Investors should recognize ALEUP.PA as a highly speculative, distressed situation requiring immediate corporate action. These …

FAQs

Why did ALEUP.PA stock fall 20% today?

ALEUP.PA declined due to severe financial distress: negative earnings of €88.61 per share, negative free cash flow, and €13.5 million working capital deficit. Investors worry about operational sustainability without restructuring or capital injection.

What is the current price and market cap of ALEUP.PA?

ALEUP.PA trades at €0.0056 on EURONEXT with a market cap of €16,596. The 99.98% annual decline reflects complete loss of investor confidence and systematic value destruction.

Is ALEUP.PA stock a buy at these levels?

ALEUP.PA remains highly speculative and distressed. With a 0.80 current ratio, negative working capital, and unsustainable debt, only extreme risk-tolerant investors should consider it after thorough restructuring due diligence.

What does Europlasma S.A. actually do?

Europlasma develops plasma torch systems for industrial waste treatment, including hazardous and asbestos waste, and produces renewable energy from waste and biomass. However, negative cash flows indicate unsustainable current returns.

When is the next earnings announcement?

Europlasma’s next earnings announcement is October 29, 2025. This will be critical for assessing operational stabilization or deterioration. Investors should monitor closely for restructuring announcements.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)